Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 445.40
+5.15 (1.17%)
At close: Sep 4, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 44.67 billion as of September 4, 2026. Its market cap has increased by 22.74% in one year.
Market Cap
44.67B
Enterprise Value
48.09B
Revenue
9.81B
Ranking
n/a
PE Ratio
60.83
Stock Price
445.40
ChartMarket Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 44.67B, an increase of 12,406.68%. That is a compound annual growth rate of 20.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 44.67B | 32.26% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi India | 72.55B |
| Bliss GVS Pharma | 71.07B |
| Morepen Laboratories | 62.30B |
| FDC Limited | 55.79B |
| Novartis India | 40.42B |
| Unichem Laboratories | 38.79B |
| Kwality Pharmaceuticals | 34.18B |
| Hikal | 27.40B |